GELS Valuation

Gelteq Ltd

Add to Watchlist

Advanced Chart

1.460

-0.08(-5.195%)1D

Overview
Forecast
Valuation
Earnings

GELS Relative Valuation

GELS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GELS is overvalued; if below, it's undervalued.

Historical Valuation

Gelteq Ltd (GELS) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of 0.00. The fair price of Gelteq Ltd (GELS) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：1.54

Fair

0.00

Trailing

Forward

0.00

EV/EBITDA

Gelteq Ltd. (GELS) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

0.00

EV/EBIT

Gelteq Ltd. (GELS) has a current EV/EBIT of 0.00. The 5-year average EV/EBIT is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBIT of 0.00 falls within the Strongly Undervalued range.

0.00

Gelteq Ltd. (GELS) has a current PS of 0.00. The 5-year average PS is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward PS of 0.00 falls within the Strongly Undervalued range.

0.00

P/OCF

Gelteq Ltd. (GELS) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/OCF of 0.00 falls within the Strongly Undervalued range.

0.00

P/FCF

Gelteq Ltd. (GELS) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward P/FCF of 0.00 falls within the Strongly Undervalued range.

Gelteq Ltd (GELS) has a current Price-to-Book (P/B) ratio of 1.18. Compared to its 3-year average P/B ratio of 1.70 , the current P/B ratio is approximately -30.73% higher. Relative to its 5-year average P/B ratio of 1.70, the current P/B ratio is about -30.73% higher. Gelteq Ltd (GELS) has a Forward Free Cash Flow (FCF) yield of approximately -19.19%. Compared to its 3-year average FCF yield of -8.38%, the current FCF yield is approximately 129.13% lower. Relative to its 5-year average FCF yield of -8.38% , the current FCF yield is about 129.13% lower.

1.18

P/B

Median3y

1.70

Median5y

1.70

-19.19

FCF Yield

Median3y

-8.38

Median5y

-8.38

Competitors Valuation Multiple

The average P/S ratio for GELS's competitors is 0.27, providing a benchmark for relative valuation. Gelteq Ltd Corp (GELS) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

NovaBay Pharmaceuticals Inc

Minerva Neurosciences Inc

Bio Green Med Solution Inc

Loss

-100.00%

2.49M

Performance Decomposition

Market capitalization of GELS increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00%to the performance.

Overall, the performance of GELS in the past 1 year is driven by Unknown.